Apr 30 2019 Topics Administrative Law & Regulation • Regulatory Transparency Project Blog Post News Over-regulation is Killing Medical Innovation – But it’s Not the Agency You Think Kristen Osenga Usually when we think about regulation of the medical industry – and specifically pharmaceuticals –...
May 5 2010 Publication White Papers Health Care Reform: Implications for the Intellectual Property Community David L. Applegate, Arthur Gollwitzer New Federal Initiatives Project Brought to you by the Intellectual Property Practice Group The Federalist Society takes no position on...
Jul 6 2009 Publication White Papers The Obama Administration’s Budget Proposal for Health and Human Services Paula M. Stannard New Federal Initiatives Project Brought to you by the Administrative Law & Regulation Practice GroupOn February 26, 2009, President Barack Obama...
Apr 18 2024 Topics Federal Courts • Federalism • Intellectual Property Blog Post The Bayh-Dole Act and the Debate Over “Reasonable Price” March-In Rights Andrei Iancu, Cooper Godfrey In 1980, Congress passed the bipartisan Patent and Trademark Law Amendments Act—better known as the...
Topics
Over-regulation is Killing Medical Innovation – But it’s Not the Agency You Think
Usually when we think about regulation of the medical industry – and specifically pharmaceuticals –...
Health Care Reform: Implications for the Intellectual Property Community
David L. Applegate, Arthur Gollwitzer
New Federal Initiatives Project
Brought to you by the Intellectual Property Practice Group The Federalist Society takes no position on...
The Obama Administration’s Budget Proposal for Health and Human Services
Paula M. Stannard
New Federal Initiatives Project
Brought to you by the Administrative Law & Regulation Practice GroupOn February 26, 2009, President Barack Obama...
Topics
The Bayh-Dole Act and the Debate Over “Reasonable Price” March-In Rights
In 1980, Congress passed the bipartisan Patent and Trademark Law Amendments Act—better known as the...